Devyser secures a major tender worth SEK 61.8 M in Udine, Italy
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a significant...
One severe complication following solid organ transplantation is antibody- and/or cell-mediated rejections of the graft. Early detection of rejection may therefore be of paramount importance to improve graft survival following solid organ transplantation. The present study was conducted to determine the monitoring capability and clinical utility of the Devyser assay designed for the sensitive detection of dd-cfDNA (donor-derived cell-free DNA) in patients following kidney transplantation.
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a significant...
Read More
The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation...
Read More
Devyser a leading provider of genetic testing solutions, has been awarded a significant tender for...
Read More
Read More